Dosing Through CRRT: Delivered Clearance, Not eGFR, Should Drive Drug Dosing
This narrative review organizes the pharmacokinetic determinants of drug exposure during continuous renal replacement therapy (CRRT) into an eight-step bedside framework that pharmacists can use to separate loading from maintenance decisions and to place therapeutic drug monitoring (TDM) appropriately.
📅 Journal publication: Oct 18, 2026·Last updated: Nov 5, 2026
CRRT demands precise drug dosing adjustments in critical care settings.
CRRT affects drug clearance in critically ill patients, requiring precise dosing to optimize therapeutic outcomes. The review outlines drug, patient, and CRRT factors influencing drug clearance, and proposes an eight-step dosing framework. This review offers a practical approach to dosing during CRRT, but requires clinical judgment and additional validation for broader application. Effective drug dosing during CRRT is complex and requires a structured, multifactorial approach.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.